Researchers have found that an existing diabetes drug can be used to halt progression of another disease that is a leading cause of liver transplants. A three-year clinical trial led by University of ...

LOS ANGELES — The continuing controversy surrounding the cardiovascular risk of the diabetes drug Avandia has led to sharp declines in its use and a surge in sales of the competing drug Actos, in part ...

San Diego, CA, June 11, 2005 - A new study presented today at the American Diabetes Association (ADA) 65th Annual Scientific Sessions showed that the type 2 diabetes drug ACTOS reduced C-reactive ...

Nevada case involves allegations that women developed cancer as a result of Actos medication. National network of attorneys is offering no-cost consultations to consumers seeking compensation over ...

Share on Pinterest New research indicates a drug used to treat type 2 diabetes may help lower the risk of dementia. Fertnig/Getty Images Researchers are saying the drug pioglitazone may help reduce ...

An unlikely medication used to treat diabetes may have a secondary role in helping smokers battle nicotine withdrawal symptoms as they try to kick the habit. New research published in the journal ...

* Better blood sugar lowering, weight loss with exenatide * 66 pct reach A1C target, vs 56 for Actos, 42 for Januvia By Bill Berkrot NEW YORK, June 6 (Reuters) - The high-profile experimental ...

PARSIPPANY, N.J. – The Food and Drug Administration has approved a Type 2 diabetes drug made by Watson Pharmaceuticals, the company said, following a federal court's order for the agency to approve ...

An older diabetes drug may help lower the risk for dementia in older people with new-onset type 2 diabetes, a Korean study suggested. Among more than 91,000 newly-diagnosed diabetes patients ages 50 ...

CHICAGO (AP) -- The widely used diabetes pill Actos appears to lower a patient's chances of death, heart attack or stroke, unlike its beleaguered chief rival Avandia, a new analysis shows. However, it ...

Mainz, Germany, May 9, 2005 – Study results published in the May 17th issue of Circulation, the journal of the American Heart Association, found that the diabetes medication pioglitazone HCl reduced ...

NEW YORK (Reuters) - The high-profile experimental once-weekly injectable diabetes drug from Amylin Pharmaceuticals Inc and Eli Lilly and Co proved superior to the widely used medicines Actos and ...